<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
< Back to all Breaking News
IKT
6/13/2022 08:06am
Inhibikase Therapeutics advances IkT-148009 Phase 2 '201' program

dynamic_feed Breaking News